• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人脑脊液中神经生成素-1水平与认知衰退及结构磁共振成像特征的关联

Association of CSF neurogenin-1 levels with cognitive decline and structural MRI features in older adults.

作者信息

Chen Suling, Ye Xinwu, Wang Qing

机构信息

Department of Psychiatry, Wenzhou Seventh People's Hospital, No. 158, Xueshiqian, Panqiao Street, Ouhai District, Wenzhou, 325018, China.

Department of Geriatric Psychiatry, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang, China.

出版信息

Sci Rep. 2025 Jul 10;15(1):24944. doi: 10.1038/s41598-025-08497-y.

DOI:10.1038/s41598-025-08497-y
PMID:40640319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12246106/
Abstract

Neurogenesis has been implicated in the pathogenesis of Alzheimer's disease (AD). However, the relationship between CSF neurogenin-1 levels and cognitive decline, as well as neurodegeneration in older adults, both with and without cognitive impairment, remains unclear. The current study included 666 individuals, comprising 161 cognitively unimpaired (CU) older adults and 505 cognitively impaired (CI) older adults. To examine the association of CSF neurogenin-1 levels with changes in cognitive performance and neurodegeneration over time, we performed a series of linear mixed-effects models. In these models, baseline CSF neurogenin-1 levels served as the predictor of interest, while cognitive measures, such as Mini-Mental State Examination (MMSE) scores, and hippocampal and ventricular volumes, served as the dependent variables. Higher CSF neurogenin-1 levels were associated with a slower rate of cognitive decline over time in the CI individuals but not in the CU individuals. Regarding structural MRI features, we found that higher baseline CSF neurogenin-1 levels were associated with a slower rate of ventricular enlargement in the CI individuals but not in the CU individuals. No association was observed between CSF neurogenin-1 levels and hippocampal atrophy in either group. Our findings suggest that neurogenin-1 may play a neuroprotective role in CI individuals, potentially slowing cognitive decline and structural brain changes associated with the disease.

摘要

神经发生与阿尔茨海默病(AD)的发病机制有关。然而,脑脊液中神经生成素-1水平与认知功能下降以及老年人(无论有无认知障碍)神经退行性变之间的关系仍不清楚。本研究纳入了666名个体,包括161名认知未受损(CU)的老年人和505名认知受损(CI)的老年人。为了研究脑脊液神经生成素-1水平与认知表现变化及神经退行性变随时间的关联,我们进行了一系列线性混合效应模型分析。在这些模型中,脑脊液神经生成素-1的基线水平作为感兴趣的预测因子,而认知测量指标,如简易精神状态检查表(MMSE)得分,以及海马体和脑室体积作为因变量。脑脊液神经生成素-1水平较高与CI个体认知功能随时间下降速度较慢相关,但与CU个体无关。关于结构磁共振成像特征,我们发现脑脊液神经生成素-1的较高基线水平与CI个体脑室扩大速度较慢相关,但与CU个体无关。两组中均未观察到脑脊液神经生成素-1水平与海马体萎缩之间存在关联。我们的研究结果表明,神经生成素-1可能在CI个体中发挥神经保护作用,可能减缓与该疾病相关的认知功能下降和脑结构变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/a8f027f79321/41598_2025_8497_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/6173f71b8d57/41598_2025_8497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/6972864cdedd/41598_2025_8497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/a8f027f79321/41598_2025_8497_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/6173f71b8d57/41598_2025_8497_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/6972864cdedd/41598_2025_8497_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c7/12246106/a8f027f79321/41598_2025_8497_Fig3_HTML.jpg

相似文献

1
Association of CSF neurogenin-1 levels with cognitive decline and structural MRI features in older adults.老年人脑脊液中神经生成素-1水平与认知衰退及结构磁共振成像特征的关联
Sci Rep. 2025 Jul 10;15(1):24944. doi: 10.1038/s41598-025-08497-y.
2
Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers.神经影像学衍生的生物脑龄及其与胶质细胞反应性和突触功能障碍脑脊液生物标志物的关联。
Mol Psychiatry. 2025 Apr 12. doi: 10.1038/s41380-025-02961-x.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.与阿尔茨海默病表型及轻度认知障碍向阿尔茨海默病转化相关的不同脑脊液α-突触核蛋白聚集谱。
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.
5
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中脑脊液淀粉样蛋白和 Tau 生物标志物的变化
JAMA Netw Open. 2025 Jul 1;8(7):e2519919. doi: 10.1001/jamanetworkopen.2025.19919.
6
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
7
Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.抗胆碱能药物减量干预措施可降低有和无认知障碍的老年患者认知能力下降或痴呆的风险。
Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD015405. doi: 10.1002/14651858.CD015405.pub2.
8
Cross-Sectional Comparison of Structural MRI Markers of Impairment in a Diverse Cohort of Older Adults.不同老年人群体中损伤的结构磁共振成像标志物的横断面比较
Hum Brain Mapp. 2025 Feb 1;46(2):e70133. doi: 10.1002/hbm.70133.
9
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.路易体(共)病理学对遗忘型患者临床及影像学表型的影响。
Brain. 2025 Jan 31. doi: 10.1093/brain/awaf037.
10
Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.轻度认知障碍患者脑脊液中生长相关蛋白43(GAP-43)升高,通过淀粉样β蛋白(Aβ)积累增加与认知障碍相关,而在阿尔茨海默病中则转变为Aβ积累减少。
J Mol Neurosci. 2025 Mar 20;75(2):39. doi: 10.1007/s12031-025-02333-8.

本文引用的文献

1
Overview of ADNI MRI.ADNI MRI 概述。
Alzheimers Dement. 2024 Oct;20(10):7350-7360. doi: 10.1002/alz.14166. Epub 2024 Sep 11.
2
Design and validation of the ADNI MR protocol.ADNI 磁共振协议的设计与验证。
Alzheimers Dement. 2024 Sep;20(9):6615-6621. doi: 10.1002/alz.14162. Epub 2024 Aug 8.
3
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.基于 SomaScan 平台的多重检测与基于免疫测定法的阿尔茨海默病脑脊液生物标志物分析方法的比较
J Alzheimers Dis. 2022;89(1):193-207. doi: 10.3233/JAD-220399.
4
Neurogenesis in aging and age-related neurodegenerative diseases.衰老和与年龄相关的神经退行性疾病中的神经发生。
Ageing Res Rev. 2022 Jun;78:101636. doi: 10.1016/j.arr.2022.101636. Epub 2022 Apr 29.
5
Implication of Adult Hippocampal Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches.成人海马神经发生在阿尔茨海默病中的意义及潜在治疗方法。
Cells. 2022 Jan 15;11(2):286. doi: 10.3390/cells11020286.
6
Molecular mechanisms of altered adult hippocampal neurogenesis in Alzheimer's disease.阿尔茨海默病中成年海马神经发生改变的分子机制。
Mech Ageing Dev. 2021 Apr;195:111452. doi: 10.1016/j.mad.2021.111452. Epub 2021 Feb 5.
7
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
8
Neurogenins in brain development and disease: an overview.神经基因在大脑发育和疾病中的作用:概述。
Arch Biochem Biophys. 2014 Sep 15;558:10-3. doi: 10.1016/j.abb.2014.05.028. Epub 2014 Jun 17.
9
Memory loss in Alzheimer's disease.阿尔茨海默病中的记忆丧失。
Dialogues Clin Neurosci. 2013 Dec;15(4):445-54. doi: 10.31887/DCNS.2013.15.4/hjahn.
10
Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores.阿尔茨海默病的进展程度通过临床痴呆评定量表总评分来衡量。
Alzheimers Dement. 2013 Feb;9(1 Suppl):S39-44. doi: 10.1016/j.jalz.2012.01.005. Epub 2012 Aug 1.